^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Altera

    Company:
    Natera
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Altera tumor genomic profiling offers a whole exome and transcriptome-based approach for Comprehensive Genomic Profiling (CGP) with boosted >500X coverage for 440 medically important genes. As a result, Altera provides full details on known cancer driver genes as well as less common biomarkers.
    Gene:
    ABL1 (ABL proto-oncogene 1), AKT1 (V-akt murine thymoma viral oncogene homolog 1), ARID1A (AT-rich interaction domain 1A), ARID1B (AT-Rich Interaction Domain 1B), AURKA (Aurora kinase A), AURKB (Aurora Kinase B)
    See More ...
    Method:
    Whole-exome and whole-transcriptome sequencing